XML 99 R126.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Data (Unaudited) - Narratives (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 20, 2018
Dec. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Interim Period, Costs Not Allocable                
Transaction related costs           $ 5.4 $ 2.1 $ 10.1
Severance costs           4.3 3.2 3.6
Share-based compensation expense           9.0 4.9 10.6
Tax benefit from changes in enacted taxes             1.8 $ 22.5
BioMedical | Disposed of by Sale                
Interim Period, Costs Not Allocable                
Gain on sale of business, net of taxes $ 34.3   $ 34.3       34.3  
Employee severance                
Interim Period, Costs Not Allocable                
Severance costs             $ 2.3  
Share-based compensation expense       $ (0.9) $ (1.8)      
Employee severance | CEO                
Interim Period, Costs Not Allocable                
Severance costs         1.4      
Compensation forfeiture                
Interim Period, Costs Not Allocable                
Severance costs       $ 1.8 3.2      
Product Warranty                
Interim Period, Costs Not Allocable                
Loss contingency accrual         $ 3.8      
Provision for loss contingencies     0.2          
AXC                
Interim Period, Costs Not Allocable                
Transaction related costs           5.4    
Integration costs   $ 1.6       $ 1.6    
VRV                
Interim Period, Costs Not Allocable                
Integration costs     $ 0.8